A detailed history of Vermillion Wealth Management, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Vermillion Wealth Management, Inc. holds 27 shares of OGN stock, worth $203. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 27 -0.0%
Holding current value
$203
Previous $257,000 10.51%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 17, 2025

SELL
$8.04 - $14.72 $24 - $44
-3 Reduced 10.0%
27 $257,000
Q1 2025

Apr 28, 2025

BUY
$14.29 - $16.41 $14 - $16
1 Added 3.45%
30 $439,000
Q4 2024

Feb 21, 2025

BUY
$14.44 - $18.83 $418 - $546
29 New
29 $433,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Vermillion Wealth Management, Inc. Portfolio

Follow Vermillion Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vermillion Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vermillion Wealth Management, Inc. with notifications on news.